Novacyt to acquire IT-IS International for $13m.

Novacyt, an international specialist in clinical diagnostics, to acquire IT-IS International, a profitable diagnostic instrument development and manufacturing company, for $13m. “We are delighted to announce this strategically important acquisition of IT-IS and we welcome the employees to the Novacyt Group. IT-IS has established a reputation as experts in the development of mobile and rapid PCR instruments. Novacyt has been working with IT-IS for more than five years through the sale of the q16 and q32 instruments. During this time, IT-IS has proven the quality, performance and reliability of its mobile PCR platform. This acquisition ensures that Novacyt is in a strong position to fulfil the growing market demands for rapid near-patient testing of COVID-19, as well as other infectious diseases," Graham Mullis, Novacyt CEO.